問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-10-18

張旭良
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

15Cases

2025-12-31 - 2029-11-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting6Sites

2025-11-25 - 2027-04-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2026-03-01 - 2031-11-10

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting6Sites

2025-10-01 - 2027-10-01

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Recruiting10Sites

2024-05-16 - 2026-12-31

Phase II

Active
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma
  • Condition/Disease

    Asthma

  • Test Drug

    injection

Participate Sites
4Sites

Recruiting4Sites

1 2